Investor AB (publ)(INVE-B) · Diversified Holdings

Investor AB: Q2 2026 Adjusted NAV of SEK 1,214.7bn or SEK 397 per Share Leaves the SEK 402.75 Quote at a 1.45% Premium Instead of the 7% to 13% Discount Normal in 2021 to 2025

Этот контент пока недоступен на вашем языке, поэтому показана английская версия.

Другие языки
КраткоОбзор простым языком · читайте это в первую очередь

Investor AB is a Wallenberg-controlled Swedish holding company owning large listed industrial stakes, wholly owned private businesses inside Patricia Industries and a strategic position in EQT AB; the report's rating is Hold. Net asset value, not a group P/E, is the right lens. Adjusted NAV was SEK 397 per share at 2026-06-30, with Listed Companies 76% of adjusted assets, Patricia 17% and EQT 7%. It is less diversified than the name count suggests: ABB and Atlas Copco alone are 36% of adjusted assets, so global industrial capex, electrification and defense drive most of the NAV.

The quality evidence is hard. Class B compounded at 21.6% a year over ten years through Q2 2026 against 12.1% for the SIXRX total-return index, long enough that luck is a weak explanation. Central management costs run at about 0.07% of adjusted NAV and leverage was 1.9%, so the wrapper consumes very little portfolio return and Investor can buy into a dislocation instead of selling into one. The moat is permanent capital plus governance access through voting stakes no ordinary shareholder can recreate. The weakness is structural: 76% of the assets can be bought directly, and Class B carries 0.1 vote per share against the Wallenberg foundation's 42.96% of the votes.

Pricing is where the report turns cautious. The B share closed at SEK 402.75 on 2026-09-10, roughly a 1.45% premium to the last reported SEK 397 NAV, though the report warns that NAV is stale. Every year from 2021 through 2025 ended at a discount of 7% to 13%, so discount compression, historically the second source of return, is spent. Stressing the Q2 asset bridge gives about SEK 420 per share in the base case, roughly 5.7% over twelve months including a SEK 5.60 dividend proxy, and about SEK 350 in the conservative case. The quote sits some 15% above that conservative value, so the margin-of-safety verdict is none and the ideal buy zone is SEK 270 to SEK 280.

Risks are concentrated rather than numerous. A de-rating of the large listed holdings would cut NAV immediately, amplified if the holding-company discount reopened. Patricia's negative 3% Q2 return against 7% organic constant-currency sales growth and 16% adjusted EBITA growth shows private marks can override operating progress. The pre-mortems put a combined de-rating at a 40% to 50% drawdown without a balance-sheet crisis. The report's stance is that the ownership model is high quality and long-horizon owners have little reason to exit because the old discount vanished, while a new buyer here has a much weaker margin of safety. The above is a summary of the report's views and does not constitute investment advice. Markets carry risk; invest with caution.

Вступление

Investor AB is the Wallenberg-controlled Swedish holding company that runs permanent industrial capital through three buckets: a listed portfolio led by ABB and Atlas Copco worth SEK 946.2bn or 76% of adjusted assets, the wholly owned Patricia Industries businesses at SEK 207.9bn excluding cash or 17%, and a SEK 88.4bn position in EQT at 7%. Q2 2026 adjusted net asset value reached SEK 1,214.7bn, or SEK 397 per share, on net debt of only SEK 23.3bn and 1.9% leverage, with the B share returning 15% against 9% for SIXRX. Rating Hold: at SEK 402.75 the shares carry a 1.45% premium to that last reported NAV rather than the 7% to 13% year-end discount normal over 2021 to 2025, so the SEK 350 conservative scenario value leaves no margin of safety and the ideal buy zone sits at SEK 270 to SEK 280.

Полный отчёт

Цены в статье указаны на момент публикации; актуальную цену см. в шкале оценки выше.

Meta

  • Ticker: INVE-B.ST
  • Company: Investor AB (publ)
  • Price & market cap: SEK 402.75 per Class B share at the 2026-09-10 close; approximately SEK 1.230tn equity market capitalization across both listed share classes, using the 2026-06-30 class counts and the 2026-09-10 A/B closing prices
  • Currency: SEK
  • Report date: 2026-09-11
  • Industry: Diversified Holding Companies
  • One-line positioning: A Wallenberg-controlled Swedish industrial holding company combining large listed stakes, wholly owned operating businesses in Patricia Industries, and a strategic stake in EQT AB.

Research scope: general research, with both a 12-month and 3–5-year investment horizon, balanced risk tolerance, and SEK as the base currency. The Class B line is the price reference because it is much more liquid. The unit of analysis is the company, not either share class. On 2026-09-10, Class B closed at SEK 402.75 and Class A at SEK 399.50. Take 1,246,763,376 A shares and 1,821,936,744 B shares outstanding before treasury adjustments and the gross market capitalization comes to about SEK 1,231.9bn; allow approximately for 5,170,019 treasury shares and it comes to about SEK 1,229.8bn, consistent with the roughly SEK 1.23tn market capitalization that market data shows.

Investor is an ordinary Swedish public limited company, an aktiebolag, whose stated object is to own and manage assets. It is not an investment trust or a closed-end regulated investment fund. The distinction is legal and economic at once, and it matters: operating subsidiaries are consolidated while the quoted portfolio is marked differently, so a consolidated group P/E or EV/EBITDA blends fundamentally unlike things. The correct valuation spine is net asset value, capital allocation and the price-to-NAV relationship.

Research summary

Investor AB is best understood as permanent industrial capital with a stock-market quote attached. Its job is to own positions large enough to matter, influence them through boards and ownership work, move capital when the risk-reward changes, and compound the resulting asset value over decades. At 2026-06-30, adjusted net asset value was SEK 1,214.7bn, or SEK 397 per outstanding share. Listed Companies accounted for SEK 946.2bn, or 76% of adjusted assets. Patricia Industries came to SEK 207.9bn excluding cash, or 17%, and Investments in EQT to SEK 88.4bn, or 7%. Net debt was only SEK 23.3bn and leverage 1.9%.

That description already explains why Investor’s consolidated income statement is a poor shortcut. The Listed Companies portfolio is primarily an ownership portfolio, while Patricia Industries contains businesses that Investor consolidates operationally. So Q2 2026 consolidated-group net sales of SEK 17.904bn and consolidated profit of SEK 117.290bn do not describe a conventional operating company whose sales turn into profit through one production system. What they combine is operating-company revenue with the accounting effects of investment ownership. Build a group multiple on those figures and you confuse accounting perimeter with economic exposure.

The portfolio is large but less diversified than the number of names suggests. At 2026-06-30 ABB alone represented SEK 279.0bn and 23% of adjusted assets; Atlas Copco represented SEK 163.8bn and 13%. Together they were about 36% of Investor’s adjusted assets. Add AstraZeneca, SEB and Saab, and the five largest listed holdings represented roughly 58% of adjusted assets. That leaves real concentration in industrial automation, electrification, capital equipment, banking and defense, even though healthcare, exchanges, telecom, private markets and consumer-facing industrial businesses broaden the economic exposure.

The private portfolio is what makes Investor more than an easily replicated basket. Patricia Industries owned, among others, Mölnlycke, Nova Biomedical, Laborie, Sarnova, Permobil, BraunAbility, Piab, Vectura and Atlas Antibodies, and it also held 40% of Tre Skandinavien. At 2026-06-30, Mölnlycke was valued at SEK 75.3bn, Nova Biomedical at SEK 31.4bn and Laborie at SEK 30.3bn. Investor’s annual report says the estimated market values are usually based on median valuation multiples of relevant listed peers or indices, commonly enterprise value to LTM operating profit or EBITDA, less net debt and adjusted for Investor’s ownership. So these are modeled private-market marks, not quoted prices.

The latest quarter illustrates exactly why private-company operating performance and private-company valuation must be kept separate. In Q2 2026, Patricia Industries’ total return was negative 3%, or negative 4% excluding cash, because valuation multiples fell. In the same quarter, the major subsidiaries’ reported sales increased 6%, organic sales in constant currencies increased 7%, reported EBITA increased 13%, and adjusted EBITA increased 16%. Investors who compress those statements into “Patricia had a weak quarter” miss the important point: the businesses strengthened while the marks weakened. Q1 showed almost the mirror image. Patricia’s estimated return was positive 4%, or 5% excluding cash, even though reported sales at the major subsidiaries fell 7%, organic constant-currency growth was only 3%, and adjusted EBITA fell 4%.

That divergence sits at the center of the current debate. Patricia can create value through organic earnings growth, acquisitions and active ownership, but the public shareholder has to accept an additional valuation layer, because its businesses do not clear every day in public markets. Buying Investor means buying the board’s judgment about those values as well as the assets themselves. The accounting is transparent about the methodology; even so, liquidity and valuation uncertainty remain real reasons for a holding-company discount.

The EQT business area needs the same care. Investor’s reference is EQT AB, the Swedish private-markets manager listed in Stockholm, not EQT Corporation, the U.S. natural-gas producer. At 2026-06-30 Investor held 183,288,016 shares in EQT AB, equal to 14.9% of its capital and votes, worth SEK 50.3bn. Separate fund investments were valued at SEK 38.1bn, taking the entire EQT business area to SEK 88.4bn. That splits into roughly 57% listed manager stake and roughly 43% underlying fund exposure.

Investor’s best argument is historical evidence, not a clever structure. At Q2 2026, Class B annualized total shareholder return was 17.5% over five years, 21.6% over ten years and 16.5% over twenty years, against 6.8%, 12.1% and 10.2%, respectively, for the SIXRX total-return index. The 2025 annual report described that year as the fifteenth consecutive year in which Investor outperformed the overall market. Outperformance sustained that long is the best evidence that the ownership model has added something beyond passive exposure.

Costs have not eaten that alpha. Management costs over the rolling twelve months to Q2 2026 were about SEK 803m, around 0.07% of adjusted NAV. Leverage was 1.9%, gross cash was SEK 28.8bn and gross debt SEK 52.1bn; average debt maturity was 8.7 years. The financial policy targets leverage of 0–10% over a business cycle and says leverage should not exceed 20% for an extended period. Against most actively managed pooled capital, a 0.07% central cost ratio is an enormous advantage, provided the ownership work continues to create value.

Control is the counterweight. Every A share carries one vote, every B share 0.1 vote. At 2026-06-30 the company had 1,246,763,376 A shares and 1,821,936,744 B shares. The Knut and Alice Wallenberg Foundation was disclosed with 20.07% of capital and 42.96% of votes; Investor’s wider ownership reporting shows the Wallenberg foundations as the enduring controlling bloc. A minority shareholder gets the economic exposure and the benefit of stable permanent ownership, but no meaningful control over that ownership system.

Liquidity partly reverses the theoretical voting premium. During 2025 approximately 760 million B shares traded versus only about 76 million A shares; turnover was roughly 42% of the B line and 6% of the A line. Investor reported average daily turnover of about 3.4 million shares across its classes and was among Nasdaq Stockholm’s most actively traded shares. That earns Class B the analytical reference despite its one-tenth voting right. Its 2026-09-10 close of SEK 402.75 was actually above the A share’s SEK 399.50 close, which shows how liquidity can outweigh the additional vote for many investors.

The capital-market story has changed. From 2021 through 2025, Investor ended each year below reported adjusted NAV, with year-end discounts of approximately 7%, 13%, 13%, 8% and 7%, respectively. At 2026-06-30, the B share stood at SEK 402.55 against reported adjusted NAV of SEK 397 per share, implying a roughly 1.4% premium on the rounded per-share figures. The 2026-09-10 B close was SEK 402.75. Set that against the still-latest official SEK 397 NAV and you get a 1.45% premium, but the comparison uses a stale NAV: the listed portfolio has moved since June, and Investor does not publish a daily official NAV. It should not be presented as a precise current premium.

This move from a persistent discount toward NAV is the market narrative that matters most now. Investor used to offer two possible sources of return: underlying NAV growth and discount compression. Near NAV, the second source is largely spent. At SEK 402.75 the buyer is primarily underwriting future compounding by ABB, Atlas Copco, the other listed holdings, Patricia Industries and EQT, plus Investor’s ability to improve the portfolio through ownership and capital allocation. The stock has become less of a cheap-wrapper proposition and more of a quality-owner one.

The strongest bull case is that this re-rating is earned. Investor combines unusually low parent costs, modest leverage, permanent capital, large voting stakes, board influence, access to private transactions and a demonstrably strong long-term TSR record. The strongest bear case: those virtues are now substantially reflected in the price. An investor can buy ABB, Atlas Copco, AstraZeneca, SEB, Saab, Nasdaq or EQT AB directly, and 76% of adjusted assets are listed. Paying around NAV for the wrapper reduces compensation for private-value uncertainty, foundation control and the possibility that recent winners such as ABB and Saab undergo multiple compression.

My qualitative portrait is high-quality compounding growth, expressed through NAV rather than a single operating P&L. “Growth” here means growth in per-share net asset value and shareholder wealth, not a conventional corporate sales CAGR. The historical record supports the quality label. The current near-NAV price makes valuation discipline more important than it was when investors could buy the same ownership machine at a double-digit discount.

Vertical company history, financial review and market narrative

Investor was born out of regulation, not entrepreneurial startup culture. A change in Swedish banking rules in 1916 constrained banks’ ability to hold industrial equities for the long term, so Stockholms Enskilda Bank moved industrial shareholdings into a separate company, Investor. The original logic was institutional: preserve long-term industrial ownership while separating it from a regulated bank balance sheet. The company’s own historical account identifies Atlas Diesel and SEB-related industrial holdings among its early roots. Investor listed on the Stockholm Stock Exchange in 1919.

There was no modern venture-to-IPO sequence: no prospectus, bookbuild, offer price or fresh-capital raise resembling a twenty-first-century listing. Investor’s current official historical materials confirm the 1919 listing, but they carry no reliable conventional IPO price or amount raised that can be reconciled to modern disclosure standards. I treat those two requested data points as insufficient information rather than manufacture precision from century-old market history.

The first stage, from 1916 through the interwar years, established the philosophy that would later matter more than the original assets. Investor had to survive war, depression and industrial distress while holding stakes that a bank could no longer house in the same way. The company’s historical materials recount years in which dividends had to be suspended, and describe the 1924 acquisition of Astra for the nominal amount of SEK 1. Hindsight makes that transaction easy to romanticize, but the real lesson lies elsewhere: permanent capital can acquire assets during periods when conventional financing and market confidence disappear.

The second stage was postwar industrial-network building. Investor became an anchor owner across Swedish engineering, telecommunications, consumer and financial businesses. This was the era in which the Wallenberg sphere became intertwined with Sweden’s international industrialization. The economic engine was less securities selection in the modern asset-management sense than concentrated, relationship-based corporate governance: patient ownership, board representation, capital provision and restructuring when necessary. That model produced the enduring advantage and the enduring governance objection at once. Investor shareholders gain access to a long-standing ownership network, while voting control remains concentrated outside ordinary public shareholders.

The third stage, broadly from the 1970s through the mid-1990s, turned that network into a more explicit restructuring machine. Swedish industry faced globalization, conglomerate restructuring and the need for larger international combinations. Patricia was created in this period, and transactions across businesses that ultimately became ABB and the Saab/Scania complex showed Investor’s willingness to use mergers, ownership changes and large capital commitments instead of simply holding a static portfolio. EQT came out of the same ownership ecosystem in the 1990s, adding an institutional private-equity capability that later became an independently listed global private-markets manager. Investor today retains a major position in EQT AB and commits capital to EQT funds.

The fourth stage, from the late 1990s through the aftermath of the global financial crisis, internationalized the portfolio and tested the balance sheet. Astra’s combination into AstraZeneca, ownership changes in Scania, the acquisition of Mölnlycke and support for portfolio companies through difficult capital-market periods pushed Investor further from being a purely Swedish listed-equity vehicle. Mölnlycke matters particularly in hindsight, because it became the cornerstone of what is now Patricia Industries: Investor could own and develop a large operating company without a public-market exit deadline.

The fifth and current stage began when Investor formalized the three-business-area model of Listed Companies, Patricia Industries and Investments in EQT. The logic is now unusually clean. Listed Companies provides liquid, observable NAV and access to global industrial franchises. Patricia contributes control, operational development and private-market compounding, while EQT carries exposure to private-markets management economics and fund investments. Since 2017, Investor has also published estimated market values for Patricia’s companies to make the private portfolio economically comparable with the quoted portfolio. EQT AB listed in 2019, but Investor remained a major owner rather than treating the IPO as an exit.

Christian Cederholm became CEO in 2024 after a career at Investor dating to 2001 and membership of the executive leadership team since 2017. His earlier responsibility for Patricia Industries matters, because the private portfolio is where the greatest valuation judgment and operating ownership are required. Jacob Wallenberg chairs the board, with Marcus Wallenberg as vice-chair. Continuity here is unusually high: management changes happen inside a system in which controlling ownership and board participation have much longer time horizons than a normal chief executive’s tenure.

The current management structure keeps asset ownership close to senior leadership. Daniel Nodhäll heads Listed Companies, Thomas Kidane and Yuriy Prilutskiy co-head Patricia Industries, and Jenny Ashman Haquinius is CFO. Cederholm personally disclosed ownership of 55,200 A shares and 180,800 B shares, 236,000 shares in total, which gives him material personal economic exposure even though the foundations remain the decisive voting owners.

For a holding company, the most informative financial vertical is per-share NAV, portfolio return, leverage, cost and cash upstreamed from holdings. The conventional consolidated revenue series is secondary: changes in consolidation scope can move it without telling us whether the shareholder became richer. Investor’s own five-year statistics show adjusted NAV per share moving from SEK 248 at 2021 year-end to SEK 220 in 2022, SEK 267 in 2023, SEK 317 in 2024 and SEK 355 in 2025. Leverage stayed around 2% across those year ends, and the central management-cost ratio held between 0.07% and 0.09% of adjusted NAV.

Dimension 2021 2022 2023 2024 2025
Adjusted NAV/share, SEK 248 220 267 317 355
Year-end NAV discount 7% 13% 13% 8% 7%
Leverage 2% 2% 2% 2% 2%
Management cost/NAV 0.07% 0.09% 0.08% 0.08% 0.07%
B-share year-end price, SEK 227.8 188.6 233.5 292.7 330.4
B-share total return 55% -15% 26% 27% 15%
SIXRX total return 39% -23% 19% 9% 13%
Listed Companies return 44% -5% 25% 18% 22%
Patricia Industries return incl. cash 2% -2% 22% 30% -9%
Investments in EQT return 111% -35% 17% 8% 15%

Source: Investor AB five-year financial summary; absolute share prices are SEK per share and leverage/return figures are percentages.

The table shows three separate compounding engines, not a synchronized portfolio. In 2021 EQT drove extraordinary gains; in 2022 it fell sharply. Patricia generated 30% in 2024 and negative 9% in 2025. Listed Companies were far steadier. That lack of synchronization is useful, since it reduces dependence on one valuation regime, but it also means reported NAV growth in any single year can come from mark-to-market changes rather than operating cash generation.

Cash upstreaming is substantial. In 2025 Investor received roughly SEK 16.2bn of dividends, of which approximately SEK 15.4bn came from Listed Companies. Patricia made about SEK 9.2bn of distributions to Investor, and EQT investment proceeds were about SEK 7.0bn. Not all of these flows are “earnings”: distributions and asset-sale proceeds can include realization of invested capital. They still show why low parent leverage is sustainable. The portfolio itself regularly replenishes the holding company’s liquidity.

Patricia’s 2025 look-through scale also clarifies what lies behind those distributions. Investor reported about SEK 68.4bn of look-through sales and SEK 17.2bn of EBITDA for the major subsidiaries plus its 40% share of Tre Skandinavien’s service revenue and EBITDA. During 2025 the portfolio made unusually large investments, including the acquisition of Nova Biomedical through Advanced Instruments in a transaction valued at USD 2.2bn; Investor reported around SEK 16bn of Patricia investment during the year. That makes the private portfolio a real capital-allocation platform, not merely a collection of legacy assets.

Investor’s return on capital should be judged through NAV and TSR, not consolidated ROIC. The B share’s 21.6% annualized ten-year TSR through Q2 2026 versus 12.1% for SIXRX is a roughly 9.5-percentage-point annual gap. A decade is long enough that pure luck becomes a less convincing explanation, particularly alongside fifteen consecutive years of market outperformance reported by the company. The caveat is that part of shareholder return came from discount compression and the rising valuation of the ownership structure itself. Future returns cannot assume that component repeats from a starting point near NAV.

The balance-sheet record is unusually conservative. Even while Investor funded acquisitions, rights issues and portfolio support, reported leverage stayed at roughly 2% at each 2021–2025 year end. At 2026-06-30 gross cash was SEK 28.8bn, gross debt SEK 52.1bn and net debt SEK 23.3bn. The resulting 1.9% leverage leaves a large gap to the stated normal range ceiling of 10%. That gives the company capacity to invest during a market dislocation without first issuing equity or liquidating its strongest assets.

The share-price history since 2021 can be read as a sequence of valuation regimes. The 2021 boom rewarded EQT and growth assets, with Investor B returning 55%. In the 2022 rate shock the B share returned negative 15%, but still materially beat SIXRX’s negative 23%; the discount widened to 13%. The 2023–2024 recovery brought returns of 26% and 27%, helped by underlying portfolio appreciation and discount narrowing. In 2025, the share returned another 15% while the year-end discount narrowed to 7%. By Q2 2026 the quoted B price had crossed the reported NAV per share on the rounded figures.

That history explains the valuation center’s shift. Investor has not transformed from low-quality to high-quality in five years; much of the quality was already present. The market has assigned more value to the structure after years of relative outperformance, very low costs, a more transparent Patricia valuation framework, and evidence that permanent ownership can produce attractive private-company outcomes. The change is partly recognition rather than a new business model. The implication for new buyers is uncomfortable: recognition is economically valuable to existing shareholders, but it reduces the next buyer’s margin of safety.

Business model, moat, industry and peers

Investor’s economic model begins with NAV, not revenue. At Q2 2026 the arithmetic was:

Dimension Listed Companies Patricia Industries Investments in EQT
Adjusted asset value, SEK bn 946.2 207.9† 88.4
Share of adjusted assets 76% 17% 7%
Pricing basis Public market Estimated private-market value Listed EQT AB plus fund NAV
Q2 2026 return 14% -3%‡ -2%

† Patricia Industries excludes cash in this presentation; cash is separately included in the NAV bridge. ‡ Patricia return was negative 4% excluding cash. Source: Investor AB Q2 2026.

The full Q2 bridge reconciles cleanly. Listed Companies contributed SEK 946.198bn; Patricia excluding cash SEK 207.905bn; EQT SEK 88.427bn; other assets and liabilities negative SEK 4.497bn; gross cash SEK 28.800bn; and gross debt negative SEK 52.100bn. Adjusted NAV comes to SEK 1,214.733bn. Divide that by 3,063,530,101 shares, which is what remains once 5,170,019 treasury shares come out of the 3,068,700,120 issued, and the answer is SEK 396.51 per share, rounding to the reported SEK 397. The cross-check earns its keep: run the issued share count without the treasury adjustment and you introduce a small error that did not need to exist.

Holding at 2026-06-30 Value, SEK bn Adjusted assets Capital owned Votes owned
ABB 279.0 23% 14.6% 14.6%
Atlas Copco 163.8 13% 17.1% 22.3%
AstraZeneca 94.0 8% 3.3% 3.3%
SEB 84.7 7% 22.1%
Saab 82.9 7% 30.2% 39.7%
Sobi 56.4 5% 34.4%
Epiroc 54.9 4% 17.1% 22.7%
Nasdaq 44.8 4% 10.3%
Wärtsilä 38.6 3% 17.7%
Ericsson 36.1 3% 9.9% 24.8%
Electrolux 4.7 <1% 18.5% 31.4%
Husqvarna 3.7 <1% 16.8% 33.9%
Electrolux Professional 2.5 <1% 20.4% 32.3%

A dash means the cited Q2 extract available for this report does not give a voting percentage clearly enough for me to reproduce it without transcription risk. Source: Investor AB Q2 2026 portfolio table.

The real listed-portfolio moat is influence, not stock selection alone. Investor’s capital stakes are often large enough to make it a reference owner, and where dual-class structures exist the voting stakes can run materially higher. At Saab it controlled 39.7% of votes on 30.2% of capital; at Ericsson, 24.8% of votes on 9.9% of capital; at Husqvarna, 33.9% on 16.8%. An individual public-market investor can replicate the economic exposure, but not those governance rights.

That advantage should not be inflated into an unobservable “Wallenberg premium.” The test that matters is whether board access and permanent capital improve long-run outcomes after costs. Investor’s long TSR record is supportive evidence, and central costs of only 0.07% of NAV set an exceptionally low hurdle. Yet the portfolio holds businesses that have gone through long stretches of disappointing operating or market performance. Active ownership does not eliminate industrial cycles or management mistakes.

Patricia is the stronger structural differentiator. Its largest private assets at Q2 2026 were Mölnlycke at SEK 75.260bn, Nova Biomedical at SEK 31.416bn, Laborie at SEK 30.265bn, Sarnova at SEK 18.870bn, Permobil at SEK 12.627bn, BraunAbility at SEK 11.085bn and Piab at SEK 11.001bn. Vectura, Atlas Antibodies, Tre Skandinavien and financial investments made up the rest. The major subsidiaries alone came to SEK 194.942bn.

Patricia holding at 2026-06-30 Investor ownership Estimated value, SEK bn
Mölnlycke 99.8% 75.3
Nova Biomedical 99.2% 31.4
Laborie 98.5% 30.3
Sarnova 95.8% 18.9
Permobil 99.6% 12.6
BraunAbility 95.3% 11.1
Piab 98.4% 11.0
Vectura 99.7% 4.0
Atlas Antibodies 95.1% 0.5

Source: Investor AB Q2 2026. Values are Investor’s estimated market values, not transaction prices.

Investor’s methodology for those marks is sensible, and it also explains where the uncertainty comes from. The house approach takes median multiples from relevant listed peers or indices, usually EV/LTM operating profit or EBITDA. Enterprise value rests on quarterly average share prices for peers and closing net debt, with operating figures open to adjustment for acquisitions and non-recurring items. Recently acquired companies normally sit at acquisition value for a period instead of being re-marked straight away with false precision.

For independent valuation I therefore do not impose one spurious multiple across all the Patricia businesses. Mölnlycke’s economic peer set sits closer to wound-care and medtech groups such as Coloplast, Convatec and Smith & Nephew; Nova and Laborie resemble diagnostic and medical-device franchises; Piab belongs nearer industrial automation; Permobil and BraunAbility occupy specialized mobility niches. Growth, margin and cyclicality profiles differ across all of them. The defensible approach at the Investor level is to start from the company’s peer-based estimated market values and stress them with portfolio-wide private-market haircuts, not to pretend that one EV/EBITDA multiple fits everything. Investor itself explicitly follows company-specific peer approaches.

The EQT exposure carries two different liquidity profiles as well. The SEK 50.294bn EQT AB stake is publicly quoted and can be marked directly. The SEK 38.133bn portfolio of EQT fund investments hangs on underlying fund valuations and realization cycles. In a private-markets downturn the manager stake may reprice instantly while underlying fund NAVs adjust with a lag, so Investor’s combined EQT line can look less volatile at first than its eventual economic value.

At the parent level the cost structure is extremely light. Its principal recurring costs are the ownership organization, financing expense and corporate infrastructure. Operating payroll, manufacturing, R&D and capex all sit inside the listed holdings or the Patricia subsidiaries. So “operating leverage at Investor” is mainly financial and valuation leverage: changes in the value of SEK 1.2tn of assets flow almost directly into NAV, while a roughly SEK 0.8bn annual management cost barely moves. Net leverage of 1.9% adds only modest balance-sheet amplification.

Four parent-level moats look defensible. Permanent capital comes first: Investor faces no fund redemptions and no private-equity realization deadline. Then governance access, through large capital and voting stakes. Third, an ownership organization that costs only around seven basis points of NAV. Fourth, balance-sheet capacity that allows countercyclical investing. The century-old reputation surrounding the Wallenberg sphere may improve access to boards, managers and transactions, but reputation belongs in the analysis as an input, not an investable moat unless it produces measurable results. The long-term TSR record is the measurable evidence.

Governance cuts both ways here, genuinely. The A/B structure gives each A share one vote and each B share 0.1 vote. On Investor’s own ownership disclosure, the Knut and Alice Wallenberg Foundation alone holds 42.96% of voting power on only 20.07% of the capital. Hostile control is therefore effectively irrelevant, and management can invest on a longer horizon than a typical quarterly-results-driven company. A B shareholder also has no way to force strategic change if capital allocation deteriorates. The same permanence that supports the moat creates the governance discount.

Investor’s industry is the set of industries sitting underneath its NAV. ABB and Atlas Copco expose it to industrial capex, automation, electrification and data-center investment. AstraZeneca, Sobi and the Patricia healthcare companies bring less cyclical medical demand. SEB carries credit, deposit and interest-rate exposure, Saab European defense spending. Nasdaq and EQT add capital-market activity and private-market fundraising, Ericsson telecom infrastructure cycles. The company is diversified against a single end market, but concentration in its largest industrial holdings means global capex remains important.

Q2 2026 put that industrial sensitivity on display. Investor specifically cited ABB’s exposure to electrification and data-center demand as an important contributor to Listed Companies’ strong quarter. Listed Companies returned 14%, helping total adjusted NAV rise 9% during the quarter after the dividend. That is economically real. It also means a reversal in the market’s willingness to capitalize data-center and electrification growth at high multiples would reach Investor even before underlying orders deteriorated.

The portfolio also runs a rate-cycle exposure, and it works through several channels. Higher yields can compress equity valuation multiples, pressure private-market marks and slow EQT fundraising or exits; they can also support parts of SEB’s revenue, depending on deposit and lending dynamics. In early September 2026, global sovereign yields were rising sharply amid oil-driven inflation concerns and expectations of tighter monetary policy. That environment raises the discount rate applied to long-duration industrial, healthcare and private-market assets even when operating results stay healthy.

Geopolitics is mixed in the same way rather than uniformly negative. European security concerns support Saab’s order environment, while trade restrictions, tariffs and supply-chain fragmentation can hurt global industrial holdings. In Q1 2026 Investor explicitly discussed tariff and foreign-exchange effects around its companies. An owner diversified across defense, industrial manufacturing, healthcare and financial infrastructure can absorb an isolated shock, but not a broad global recession or de-rating.

The most useful direct peer is Industrivärden, another Swedish listed active owner built around large strategic positions in listed Nordic businesses, with a similarly long horizon and concentrated governance stakes. For Investor’s Listed Companies business it is a cleaner benchmark than a global asset manager. On 2026-07-31 Industrivärden reported NAV of SEK 523 per share while its A and C shares closed at SEK 549 and SEK 544, respectively, implying premiums of roughly 5% and 4% at that snapshot. That is important evidence that the Swedish market in 2026 has been willing to value certain high-quality active-owner structures at NAV or slightly above it.

Lundbergföretagen is the governance comparator, a family-controlled Swedish holding company with long-duration stakes and property exposure. Its portfolio differs materially from Investor’s, which weakens any direct multiple comparison, but its existence shows that concentrated control itself does not mechanically force a discount. Lundberg reported NAV after deferred tax of SEK 149.3bn, or roughly SEK 602 per share, at 2026-03-31; a later April 2026 company update reported NAV around SEK 652 per share.

GBL, Sofina and Exor form the broader European comparison group. GBL combines concentrated public positions with private assets; Sofina is a family-controlled permanent-capital investor with large private-market exposure; Exor is a controlling industrial holding company built around the Agnelli family’s strategic holdings. Their value is conceptual: European holdco discounts tend to widen when private assets are opaque, taxes or overhead are material, capital allocation is questioned, or investors can replicate the quoted holdings cheaply. Investor scores unusually well on central costs, leverage and disclosure, which supports a narrower discount than a generic European holdco. Its 17% Patricia exposure and foundation control still argue against treating a premium as automatic. The Investor-specific evidence comes from its own cost, leverage and NAV disclosures.

The ecological niche is therefore distinctive: Investor is a permanent-capital active owner sitting between a listed investment company and an industrial conglomerate. It manufactures no single product, gathers no outside assets for an annual management fee, and harvests no predetermined fund. Its profit pool is the long-term increase in the value of controlled and influential stakes. A shareholder’s closest substitute is to build the liquid 76% of the portfolio directly and forgo Patricia, Investor’s voting influence and centralized capital allocation. That replicability is the most important structural ceiling on how large a sustained premium should become.

Current fundamentals, valuation and risk

The latest two quarters show an unusually strong public portfolio and improving private-company operations. Q1 2026 adjusted NAV was SEK 1,125.1bn, or SEK 367 per share, up 3% in the quarter. The B share returned 7%; SIXRX declined 1%. Listed Companies returned 5%, and Investor bought SEK 142m of Nasdaq shares and SEK 30m of Atlas Copco while selling SEK 1.520bn of SEB. EQT investments fell 13% in value even as Investor bought another SEK 1.378bn of EQT AB stock. Leverage was only 1.2%, with gross cash of SEK 37.378bn.

Q2 accelerated sharply at the NAV level. Adjusted NAV rose SEK 106.8bn during the quarter, dividend included, to SEK 1,214.7bn, or SEK 397 per share. The B share’s total return was 15%, against 9% for SIXRX. Listed Companies returned 14%. Investor put SEK 1.701bn into Electrolux’s rights issue, bought SEK 46m of Nasdaq shares and agreed to sell 2 million SEB shares.

Patricia’s operating numbers were better than its valuation return. The major subsidiaries grew reported Q2 sales by 6%; organic constant-currency growth was 7%; reported EBITA increased 13%; adjusted EBITA increased 16%. Mölnlycke grew organically by 2%, including 2% growth in Wound Care, and improved underlying EBITA margin. Mölnlycke also distributed EUR 200m to Patricia. Laborie delivered double-digit sales growth and improved profitability, while Nova posted roughly 10% organic growth and earnings growth around 20%. Piab was weaker as restructuring and commercial-organization costs hurt profitability.

Taken together, Q1 and Q2 reduce one bear concern and strengthen another. The operating recovery argues against the idea that Patricia’s 2025 negative 9% return signaled broad deterioration of the underlying companies. Yet the negative 3% Q2 return despite much stronger EBITA confirms that private-market multiples can override operating growth over shorter periods. The valuation methodology is working as intended; it is also reminding shareholders that private marks are not cash.

EQT remains a more cyclical piece of the portfolio. In Q2 the EQT business-area value declined 2%, with net cash flow to Investor of SEK 520m, and Investor bought SEK 349m more EQT AB shares. Together with the much larger SEK 1.378bn Q1 purchase, management was adding to EQT through a period of weaker market marks rather than treating volatility as a reason to reduce exposure. That fits Investor’s permanent-capital philosophy, though shareholders still carry the private-market fundraising and realization cycle.

The market at SEK 402.75 is therefore trading three narratives at once: genuine earnings and cash-flow improvement inside Patricia; strong listed-portfolio momentum, particularly in industrial electrification, automation and defense; and a structural re-rating of Investor itself from a discounted wrapper toward a near-NAV “quality owner.” The first two can continue through business performance. The third cannot provide the same tailwind once the discount has already disappeared.

The current bull-bear dispute can be framed precisely. Bulls point to the ten-year B-share TSR of 21.6% a year, the 0.07% management cost ratio, 1.9% leverage and private-company operating acceleration as evidence that near-NAV pricing is rational. Bears counter with 76% of adjusted assets being publicly listed, 36% concentrated in ABB and Atlas Copco, private marks representing another 17%, and a price that no longer contains the 7–13% year-end discount seen during 2021–2025. Both arguments are factually coherent. The disagreement is about how much of Investor’s historic alpha can persist after the structural discount has been largely re-rated away.

Historical valuation supports caution rather than outright bearishness. A 7–13% year-end discount was normal over the 2021–2025 sample. At Q2 2026, the rounded SEK 402.55 B-share price stood 1.4% above the rounded SEK 397 NAV. Revert merely to a 7% discount on an unchanged SEK 397 NAV and the implied price would be approximately SEK 369 per share; go back to the 13% discount seen in 2022–2023 and it would be about SEK 345. The discount alone can therefore create a mid-teens price decline without any impairment of the underlying businesses.

The current 2026-09-10 B price is only SEK 0.20 above the Q2-end B price, but the listed holdings have moved in the intervening period. Official Investor disclosure cannot pin down the exact current discount or premium until the company updates NAV. The honest current statement is therefore: SEK 402.75 represents a roughly 1.45% premium to stale 2026-06-30 reported NAV, not a verified 2026-09-10 premium.

Cash-flow passthrough requires a holding-company adaptation. A five-year consolidated operating-cash-flow/net-income ratio is not economically comparable to the same ratio at a manufacturer: listed investment returns and fair-value changes influence accounting profit, while full operating cash flows of consolidated Patricia subsidiaries enter the group cash-flow statement. Using that ratio to value Investor would violate the same perimeter discipline that makes group P/E misleading.

For the same reason, no numeric parent-level split between maintenance and growth capex can be produced responsibly. Maintenance capex belongs inside Mölnlycke, Laborie, Nova and the other operating subsidiaries, while ABB, Atlas Copco and the quoted holdings finance their own capex outside Investor’s consolidated operating perimeter. Investor’s public adjusted-NAV disclosure does not provide a complete, comparable maintenance-capex figure across all those holdings. Inventing one would create false precision. The economically relevant owner-cash measures are dividends, distributions and realized proceeds upstreamed to Investor, together with central cost and net interest.

That owner-cash lens is healthy. In 2025 dividends received totaled approximately SEK 16.2bn and Patricia distributions approximately SEK 9.2bn, while central management cost remained around 0.07% of NAV. The caveat: distributions and realization proceeds are not equivalent to recurring free cash flow. The primary source of value remains NAV appreciation, so there is no legitimate “owner-earnings P/E” that improves on NAV-based valuation here.

My absolute valuation starts from the official Q2 NAV bridge and stresses each asset bucket separately. This is scenario analysis within a research framework, not investment advice.

Dimension Conservative Base Optimistic
Listed Companies assumption 10% below Q2 marks 6% above Q2 marks 20% above Q2 marks
Patricia assumption 20% haircut to Q2 estimated value 5% above Q2 value 20% above Q2 value
EQT assumption 15% haircut 5% above Q2 value 25% above Q2 value
Gross cash, SEK bn 28.8 unchanged 28.8 unchanged 28.8 unchanged
Gross debt, SEK bn 52.1 unchanged 52.1 unchanged 52.1 unchanged
Implied adjusted NAV/share, SEK ≈348 ≈420 ≈479
Rounded scenario value/share, SEK 350 420 480
12-month return incl. SEK 5.60 dividend proxy -11.7% +5.7% +20.6%
3–5 year NAV/return regime Low-single-digit NAV growth, discount returns High-single-digit NAV growth, modest discount Low-teens NAV growth, near-NAV valuation
Main catalyst Better entry price after de-rating Continued PI earnings growth and portfolio compounding Strong industrial/private-market cycle
Permanent-loss trigger Broad asset de-rating plus discount widening Private valuations fail to follow cash earnings Market prices sustained exceptional growth that later reverses

Calculations use 3,063,530,101 shares net of treasury and the Q2 2026 NAV components disclosed by Investor. Scenario returns use the 2026-09-10 B-share close of SEK 402.75 and SEK 5.60 per share as an annual dividend proxy based on the 2025 dividend level; the dividend is an assumption, not guidance for the next twelve months.

The conservative case is intentionally more severe than a normal 7% holdco discount. It cuts the asset values first: Listed Companies by 10%, Patricia by 20% and EQT by 15%. On the Q2 balance sheet those assumptions produce about SEK 348 per share before rounding to SEK 350. A conventional discount applied on top would drive the tradable price lower still. That is why a genuine “ideal buy” price under the framework ends up well below today’s quote. It is a margin-of-safety requirement, not a forecast that SEK 270–280 is likely.

The base case applies modest appreciation to the underlying assets rather than assuming more discount compression: plus 6% for Listed Companies and plus 5% each for Patricia and EQT, with cash and debt unchanged. That works out to about SEK 420 per share. From SEK 402.75, including a SEK 5.60 dividend proxy, the one-year total return is only about 5.7%. For a company of Investor’s quality that is respectable, but it is not a large prospective return relative to the historical 21.6% ten-year TSR.

The optimistic case requires broad participation: Listed Companies 20% above Q2, Patricia 20% higher and EQT 25% higher, resulting in approximately SEK 479, rounded to SEK 480 per share. It does not require a large holdco premium. That distinction matters. I am willing to underwrite business and NAV growth in a bull scenario; I am reluctant to make persistent premium expansion the core source of value because most of the liquid portfolio can be bought directly.

Peer evidence argues that a zero discount is possible. Industrivärden traded at a small premium to its reported NAV at the end of July 2026. Investor arguably deserves at least comparable recognition for its low cost base and long TSR record, but it also has more private-valuation exposure. The current valuation is therefore defensible rather than obviously irrational. Defensible is a lower bar than attractive.

The expectation gap lies mainly in Patricia and in the valuation of the largest public holdings. If Patricia keeps producing mid-to-high-single-digit organic sales growth and double-digit adjusted EBITA growth while private multiples stabilize, its Q2 valuation/operating divergence closes favorably. Should ABB, Atlas Copco and Saab keep compounding but lose part of their valuation premium, operating success may fail to generate equivalent Investor NAV growth. The next major print therefore matters less for consolidated revenue than for adjusted NAV, Patricia organic growth and EBITA, portfolio cash flows, leverage and commentary around private-market multiples.

The margin-of-safety check is more demanding. SEK 402.75 stands about 15% above my rounded SEK 350 conservative value, so the margin of safety against that scenario is zero. The most fragile non-listed assumption is Patricia’s estimated market value. If the Patricia component embedded in the base case were abruptly marked to 70% of that assumed value, roughly SEK 20–22 per share would disappear from base NAV, taking the SEK 420 base case to around SEK 399–400 per share. That alone would absorb almost all the apparent base-case upside. This is arithmetic from Investor’s disclosed Patricia value rather than a forecast that such a write-down will occur.

A flat three-year case is also unexciting. With no NAV growth and no change in the price/NAV relationship, a flat SEK 5.60 annual dividend would yield only about 1.39% on the SEK 402.75 purchase price before reinvestment and tax. I did not retrieve a sufficiently reliable official Swedish ten-year government-bond closing yield for 2026-09-10 from the available source set, so I will not manufacture the exact bond comparison required by the template. Global sovereign yields were nevertheless rising sharply in early September 2026, which makes a 1.39% flat-equity cash return weak standalone compensation for equity risk.

Margin-of-safety sufficiency verdict: none.

The permanent-loss risks are concentrated rather than numerous. The first is an underlying listed-asset de-rating. Probability is medium and impact high because 76% of assets are listed and ABB plus Atlas Copco are 36% of total adjusted assets. Order growth, margins and valuation changes at the large industrial holdings are the observable indicators. The transmission path is direct: lower public prices reduce Investor NAV immediately, while a simultaneous re-expansion of the holdco discount magnifies the share-price fall.

The second is private-value disappointment. Probability is medium and impact medium-to-high. Patricia’s Q2 businesses were operating well, but their total return was negative because multiples fell. The indicator is a sustained gap in which organic sales and adjusted EBITA grow while estimated market values fall or fail to follow. If that persists, either market multiples are correcting from an excessive level or Investor’s marks previously embedded too optimistic a valuation. Both paths lower the value investors should place on Patricia.

The third is governance/capital-allocation drift. Probability is low, impact high. The Wallenberg structure makes control exceptionally stable, and long-term results have so far been strong. But outside B shareholders possess only 0.1 vote per share and cannot readily alter strategy. Indicators would include repeated large acquisitions that fail to earn their cost of capital, persistent leverage increases toward the top of the 0–10% range, or a multi-year deterioration in NAV growth relative to SIXRX. Once confidence in the owner itself is damaged, the loss path includes both weaker NAV and a structurally wider holdco discount.

The fourth is a private-markets and financing-cycle shock. Probability is medium, impact medium. EQT AB plus EQT funds are only 7% of adjusted assets, but the same high-rate environment that hurts fundraising and exits can simultaneously compress Patricia multiples and listed-equity multiples. That correlation makes a rates shock more dangerous than the 7% EQT weight implies. Global bond yields were moving higher in September 2026 amid inflation and energy concerns, so this is a current rather than theoretical variable.

The fifth is concentration disguised as diversification. Probability of ordinary volatility is high; probability of permanent loss is medium. Investor owns many businesses, yet ABB, Atlas Copco, AstraZeneca, SEB and Saab account for about 58% of adjusted assets. A synchronized industrial/global-capex downturn or a valuation reversal in the largest winners would overwhelm good performance in the smaller holdings. The indicator is the contribution of the five largest names to NAV change each quarter.

Catalysts, tracking and cross-synthesis

Near-term positive catalysts are straightforward. Continued 7%-type organic constant-currency growth and double-digit adjusted EBITA growth at Patricia would mark Q2 as more than a rebound quarter, and stabilizing private-market multiples would then let that operating progress show up in estimated values. Strong orders and margins at ABB and Atlas Copco would protect the two largest NAV contributors. Better private-market realization conditions would help both EQT AB and Investor’s EQT funds. A renewed holdco discount is the paradoxical one: it could improve the prospective return for new shareholders if it came without deterioration in underlying NAV.

Negative catalysts include the mirror image: a Patricia quarter in which organic growth stalls and margins fall, a material correction in ABB or Atlas Copco, further private-market multiple compression, rising leverage associated with a large acquisition, or a broad risk-free-rate shock that de-rates public and private assets simultaneously. A share-price premium to NAV that widened materially without faster NAV growth would also be a negative valuation catalyst, because it would convert more of the expected return into dependence on sentiment.

Tracking indicator Recent reference Normal/desired zone Alert threshold
Adjusted NAV/share SEK 397 at 2026-06-30 Positive multi-year CAGR Two consecutive quarters of material decline
B-share price/NAV ≈1.01× stale Q2 NAV at 2026-09-10 About 0.90–1.00× >1.10× without faster NAV growth
Parent leverage 1.9% at 2026-06-30 0–10% policy range >10%; serious concern toward 20%
Management cost/NAV 0.07% rolling 12m ≤0.10% >0.15% persistently
Patricia organic CC sales growth 7% in Q2 2026 >4% ≤0% for two quarters
Patricia adjusted EBITA growth 16% in Q2 2026 >5% Negative for two quarters
Listed concentration ABB + Atlas 36% of assets <40% >45% without deliberate rationale
EQT share of adjusted assets 7% 5–10% >15% through price or new capital
Gross cash SEK 28.8bn Ample against commitments <SEK 10bn alongside rising leverage
Next scheduled earnings report Q3 2026, October 2026§ Any material deviation from stated calendar

§ Investor’s annual reporting calendar is the appropriate primary source for the next release; the precise October date should be re-verified immediately before trading, because corporate calendars can change. The current report’s source set does not let me re-open that calendar and independently revalidate the exact day without guessing. All other reference values are Investor Q2 2026 data.

NAV per share is the dashboard’s master variable. Patricia’s operating growth earns a separate line because its quarterly return can move in the opposite direction from operations, as Q1 and Q2 2026 showed. Leverage and gross cash show whether Investor can remain opportunistic in a downturn. And the price/NAV ratio tells investors whether they are being paid to accept the holding structure or paying extra for it.

Looking across 110 years rather than a few quarters, the capability Investor has actually proven is capital stewardship through changing industrial eras. It began because regulation forced industrial stakes out of a bank, survived periods when portfolio companies were distressed, participated in the international consolidation of Swedish industry, created a private-company ownership arm and remained a cornerstone owner as EQT grew into a listed private-markets manager. The common thread running through all of that is the ability to maintain permanent capital, concentrated governance positions and financial flexibility while industries change around the portfolio, not one sector or one chief executive.

Some of Investor’s success clearly came from era tailwinds. Swedish industrial champions internationalized successfully; falling interest rates supported equity multiples for much of the post-financial-crisis period; private markets grew into a major asset class; and recent electrification, data-center investment and European defense spending have benefited several large holdings. None of that counts as a repeatable managerial invention. The stronger evidence for skill is that Investor outperformed through multiple different regimes, including the 2022 market decline, while maintaining approximately 2% leverage rather than amplifying returns with a fragile balance sheet.

Its real horizontal advantage over other holding companies is the combination rather than any one element. Industrivärden offers similarly credible Swedish active ownership of listed assets; Lundberg offers stable family control; European groups such as Exor and GBL offer permanent capital and private assets. What Investor puts inside one wrapper is a very large liquid portfolio, controlled private operating companies, a strategic stake in a global private-markets manager, low central costs and a remarkably liquid publicly traded share. The 0.07% central cost ratio is particularly difficult for a conventional active fund structure to match.

Its weakness is equally structural. A large part of the equity value is exposure investors can buy directly. ABB and Atlas Copco alone account for 36% of adjusted assets; the entire Listed Companies area is 76%. A shareholder with a strong positive view on ABB does not need Investor to express it. Investor must therefore create enough extra value through ownership, allocation and Patricia to compensate for loss of control, private-value uncertainty and any holdco discount. For the past decade it has done so. The question at SEK 402.75 is whether the buyer is being paid enough to assume that continues.

The current price increasingly rewards past success. In 2022–2023 an investor could buy the ownership system at a 13% year-end discount to adjusted NAV; at Q2 2026 the B share was around reported NAV. If the underlying assets subsequently compound at an attractive rate, shareholders can still do well. The return equation has nevertheless lost a favorable term: discount closure. A five-percentage-point contraction in a 13% discount is meaningful free return, and there is no comparable free return once the stock already trades around NAV.

The market may be underestimating Patricia’s operating momentum. Q2’s 7% organic constant-currency growth and 16% adjusted EBITA growth were strong relative to the negative 3% reported total return. Let those operating trends persist for several quarters and a static or falling private mark would eventually become increasingly conservative. That is the cleanest source of upside that does not depend on public-market multiple expansion.

The market may simultaneously be underestimating how much of Investor’s recent return came from a friendlier valuation of the wrapper and of its largest holdings. A portfolio can contain excellent companies and still produce mediocre shareholder returns when purchased at an elevated starting value. Investor’s own five-year record shows the discount moving from 13% in 2022–2023 to 7% in 2025 and effectively around zero at Q2 2026. That tailwind is mathematically close to exhausted.

Over the next twelve months, the critical variables are Patricia’s earnings conversion into estimated market value, the prices and operating momentum of ABB and Atlas Copco, and whether Investor continues to trade around NAV or reverts to a discount. On a three-year view, capital allocation matters more: acquisitions inside Patricia, Investor’s deployment of balance-sheet capacity, EQT’s private-market cycle and whether current industrial winners can sustain earnings growth. Five years out, the decisive question is whether NAV per share continues to outperform a broad Swedish total-return benchmark after the benefit of discount compression disappears.

A better investment setup would combine one of two conditions. The cleanest is a lower share price with intact operating evidence: Patricia still growing, leverage still below 10%, major holdings still financially healthy, but Investor B trading at a high-single-digit or low-double-digit discount. The second is much faster NAV growth, lifting conservative and base intrinsic values above the current price without relying on a premium. A worse setup would be the reverse: slower portfolio earnings, private marks still high, leverage rising and the share maintaining a premium because investors extrapolate the historical TSR record.

Bull reasons:

  • Investor B has compounded at 21.6% annually over ten years through Q2 2026 against 12.1% for SIXRX, evidence that the ownership structure has historically added substantial shareholder value.
  • Central management costs run at only about 0.07% of adjusted NAV, so the wrapper consumes very little portfolio alpha.
  • Patricia’s Q2 2026 major subsidiaries grew organic constant-currency sales 7% and adjusted EBITA 16% even while their valuation return was negative, which leaves potential upside if multiples stabilize.
  • Leverage of 1.9% and SEK 28.8bn of gross cash leave Investor able to deploy capital in a downturn instead of being forced to sell assets.
  • Large voting positions give Investor influence that public shareholders cannot recreate just by buying the same quoted stocks.

Bear reasons:

  • The B share has moved from the 7–13% year-end discounts seen in 2021–2025 to around reported NAV, and that removes a historically important source of prospective return.
  • Listed Companies are 76% of adjusted assets, ABB plus Atlas Copco alone 36%, leaving Investor exposed to a public industrial-valuation reversal despite the appearance of broad diversification.
  • Patricia’s Q2 negative 3% return despite strong earnings shows that private valuation multiples can overwhelm operating progress, and those marks carry no continuous market-price verification.
  • Class B carries only 0.1 vote per share, while the Knut and Alice Wallenberg Foundation alone controls 42.96% of votes, so minority shareholders have little ability to change strategy if future capital allocation weakens.
  • At SEK 402.75, my base scenario offers only about 5.7% twelve-month total-return potential using a SEK 5.60 dividend proxy, and the conservative scenario is worth roughly SEK 350.

The first pre-mortem starts with the industrial leaders. During 2027–2028, data-center and electrification capital spending normalizes after several strong years; ABB and Atlas Copco continue to grow only modestly, but their market multiples contract enough to cut the value of Investor’s combined 36% exposure by roughly 25%. The rest of Listed Companies fall 10%, Patricia is marked down 15% as comparable multiples decline, and the holdco discount returns to 13%. On simplified Q2 asset weights, that combination can push Investor’s share price toward the low-SEK-300s even without a balance-sheet crisis. A deeper recession combined with earnings declines could take the loss toward 40–50%. This is a valuation-plus-cycle failure, not an insolvency script.

The second pre-mortem starts inside the ownership model. By 2028, a series of expensive Patricia acquisitions fails to produce the expected organic growth; adjusted EBITA growth turns negative for several quarters, while EQT fund realizations slow in a high-rate environment. Investor uses more debt to continue investing, leverage rises above the normal 0–10% range, and the market concludes that the prior decade’s capital-allocation advantage has weakened. NAV falls 20%, while the share moves from around NAV to a 20–25% discount. That two-layer contraction produces a roughly 35–40% loss; adding a concurrent 15–20% listed-market correction creates a plausible path to a 50% drawdown. The critical signal would be sustained weak NAV relative performance accompanied by rising leverage, rather than ordinary quarterly volatility.

Investor remains one of the more credible permanent-capital structures in European public markets. The evidence for quality is unusually hard: multi-decade TSR, fifteen consecutive years of reported market outperformance through 2025, parent costs around seven basis points of NAV, a lightly levered balance sheet, significant governance stakes, and an unlisted portfolio whose latest operating data are improving. I would rather own that structure than a high-cost holding company whose discount merely reflects mediocre capital allocation.

Price is now doing more of the work against the buyer. The 2026-09-10 B close of SEK 402.75 is already above the last officially reported SEK 397 NAV, although that NAV is stale and cannot establish today’s true premium. My base asset scenario reaches about SEK 420 per share, leaving limited near-term upside, while the conservative stress value is roughly SEK 350. The stock therefore fits a high-quality-company/fair-to-full-price diagnosis rather than a classic discounted-holding-company opportunity. Existing long-horizon owners have little fundamental reason to exit solely because the old discount disappeared; a new buyer has a much weaker margin of safety.

【Company-profile scores】

  • Fundamental quality: high
  • Growth: medium
  • Moat: strong
  • Financial soundness: strong
  • Management credibility: high
  • Valuation attractiveness: medium
  • Risk level: medium
  • Suitable investor type: long-term growth / value / dividend

【Investment rating】

  • Rating: Hold
  • One-line thesis: Exceptional long-term ownership economics and a 1.9%-levered balance sheet are largely recognized now that Investor trades around its last reported NAV.
  • Current-price classification: acceptable hold.
  • Whether to wait for a better price: yes for a new position seeking a meaningful margin of safety. The preferable setup is SEK 280 or below with Patricia still growing, leverage below 10%, and no evidence of permanent impairment in the largest listed holdings. The opportunity cost is that NAV may continue to compound and the old discount may never fully return.
  • Target holding horizon: 3–5 years, preferably 5+ years for investors using Investor as a permanent-capital core holding.
  • Expected annualized return: conservative 12-month scenario about negative 11.7%; base about positive 5.7%; optimistic about positive 20.6%, each including a SEK 5.60 dividend proxy. For 3–5 years I would underwrite roughly 3–5%, 8–10% and 12–14% annualized, respectively, with considerably wider uncertainty because future discount/premium behavior is not forecastable from operating results alone.
  • Max-loss risk: about 40–50% in a combined industrial/private-market de-rating in which NAV falls materially and the holdco discount simultaneously widens toward 20–25%; a balance-sheet crisis is not required for that drawdown.
  • Reassessment-trigger signals: leverage above 10% without an obviously temporary transaction; Patricia organic constant-currency sales growth at or below 0% for two consecutive quarters; Patricia adjusted EBITA declining for two consecutive quarters; three-year NAV/TSR underperformance against SIXRX large enough to challenge the ownership-alpha thesis; or a persistent market premium above 10% to contemporaneous NAV without faster underlying NAV growth.

【Ideal Buy Price】270–280 SEK

Basis: the range sits at least 20% below my rounded SEK 350 conservative value. It is intentionally demanding because Investor no longer offers the historical 7–13% discount on top of a stressed asset value.

  • Acceptable hold price: SEK 385–440, centered around the SEK 420 base scenario.
  • Clearly overvalued price: SEK 530–560, beginning more than 10% above the SEK 480 optimistic scenario.

【Valuation Range】

  • current: 402.75 SEK (close as of 2026-09-10)
  • bear (conservative · ideal buy zone): [270, 280]
  • base (fair · acceptable hold zone): [385, 440]
  • bull (optimistic · above the clearly-overvalued line): [530, 560]

The current SEK 402.75 price lies inside the base acceptable-hold band. That is consistent with Hold: the evidence supports the quality of the asset and ownership model much more strongly than it supports a large margin of safety at today’s quote.

Sources and research uncertainties

Most of the work rests on Investor AB’s Q2 2026 interim report and its portfolio tables, the source for adjusted NAV, portfolio weights, Patricia operating results, EQT exposure, debt, cash, leverage and quarterly returns. The Q1 2026 report sits alongside it to separate operating trends from valuation movements across consecutive quarters.

Investor’s 2025 annual report covers the longer view: the five-year NAV/discount/return history, the private-company valuation methodology, historical shareholder-return context, Patricia look-through figures, ownership background and long-term company history. The one-vote versus 0.1-vote distinction rests primarily on the Articles of Association. Current share counts, treasury shares and the Knut and Alice Wallenberg Foundation’s capital and voting position come from Investor’s ownership disclosure.

The 1916 regulatory origin and the 1919 Stockholm listing trace to Investor’s own corporate-history materials. For the current CEO, chairman and executive team, the source is management and board disclosures.

Market prices are the 2026-09-10 closing quotes for both share classes. The reason is timing: the research base date of Friday, 2026-09-11 fell before the Stockholm market open when the current-price check was performed. B closed at SEK 402.75 and A at SEK 399.50. Valuation uses the B line throughout.

Peer evidence leans mainly on the companies’ own reported NAV snapshots. Industrivärden’s 2026-07-31 NAV and quoted prices earn their place because they show another Swedish active-owner vehicle trading above NAV in 2026. Lundbergföretagen’s 2026 NAV disclosures give the family-controlled Swedish reference. None of these are exactly same-day observations. They support the qualitative peer conclusion, not a false-precision cross-sectional regression.

There are four material research blind spots. First, no official Investor NAV exists for 2026-09-10; the latest is 2026-06-30, so any “current discount” calculated from SEK 397 is necessarily stale. This report explicitly avoids treating the resulting 1.45% premium as a live NAV premium.

Second, Investor discloses Patricia’s methodology and estimated values, but the Q2 portfolio table stops short of publishing every company-specific peer multiple, adjustment and private-company net-debt bridge. The independent scenarios therefore stress Investor’s disclosed marks instead of reconstructing an unverifiable shadow valuation company by company.

Third, a true five-year consolidated OCF/net-income ratio and a maintenance-capex/owner-earnings P/E would be conceptually misleading for this legal structure. The limitation is methodological, not a gap in the arithmetic: consolidating Patricia and the different accounting treatment of quoted investments leave those ordinary-company measures non-comparable. NAV and upstream cash flows are the better lens.

Fourth, the available evidence set did not provide a reliable official 2026-09-10 Swedish ten-year government-bond closing yield or allow a final re-check of the precise October 2026 Q3 reporting date. Those two items are not stated here with invented precision. The global rate environment in early September 2026 was clearly one of sharply higher sovereign yields, which is sufficient for the direction of the valuation-risk argument but not for an exact Swedish risk-premium calculation.

Other tickers mentioned

  • ABBN.SW: Investor’s largest listed holding and the biggest single contributor to current NAV concentration.
  • ATCO-A.ST: Investor’s second-largest listed holding and a major source of industrial-capex exposure.
  • AZN.US: major pharmaceutical holding that carries defensive healthcare exposure.
  • SEB-A.ST: major banking holding and an important link to Investor’s Wallenberg ownership history.
  • SAAB-B.ST: large defense holding whose re-rating and the European defense cycle materially affect NAV.
  • NDAQ.US: exchange and market-infrastructure holding; Investor kept buying shares in it during 2026.
  • EQT.ST: Swedish private-markets manager; this is the EQT relevant to Investor, not the U.S. natural-gas producer.
  • INDU-C.ST: Industrivärden share class, used here as a Swedish active-ownership peer.
  • LUND-B.ST: Lundbergföretagen share class, a Swedish family-controlled holding-company peer.
  • GBLB.BR: Belgian diversified holding company, taken as a broader European holdco reference.
  • SOF.BR: family-controlled Belgian investment company, a private-market/permanent-capital reference.
  • EXO.AS: Agnelli-controlled permanent-capital holding company, standing in as a European strategic-owner reference.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.

ABBNATCO-AAZNSEB-ASAAB-BNDAQEQTINDU-CLUND-BGBLBSOFEXO

NAV Premium vs Historical DiscountWallenberg Permanent CapitalPatricia Industries Private MarksListed-Portfolio ConcentrationHoldco Discount Re-RatingEQT Private-Markets Cycle
Вопросы читателей10

Фреймворк Baillie · Десять вопросов об инвестициях в рост

10

Поиск десятилетних пятикратников среди великих акций роста — главный вопрос об апсайде: «Может ли она стать гораздо крупнее?»

Фреймворк Baillie · Десять вопросов об инвестициях в рост — score profile: 44/100 total Ceiling 4/10 · Revenue 2x 3/10 · Next engine 4/10 · Moat 6/10 · Reinvention 6/10 · Management 7/10 · Customer need 4/10 · Unit economics 5/10 · 5x path 2/10 · Blind spot 3/10 0510 How high is its market ceiling — is it growing a slice of an existing pie, or creating an entirely new market? — 4/10 Ceiling 4 Can its revenue at least double over the next five years? Is that growth driven mainly by volume, price, or new businesses? — 3/10 Revenue 2x 3 Five years out, what takes over as the next growth engine? Does that “second curve” exist today? — 4/10 Next engine 4 What is its core competitive advantage? Will that moat widen or narrow over the next three to five years? — 6/10 Moat 6 If its core business were disrupted, does it have the DNA to reinvent itself? How does it handle mistakes and bad news? — 6/10 Reinvention 6 Does management — the founders especially — hold a long-term view with interests deeply tied to the company? Are they willing to sacrifice current profit for the payoff five to ten years out? — 7/10 Management 7 If it disappeared tomorrow, how badly would customers miss it? Is the way it grows sustainable, without relying on harm to society or regulators? — 4/10 Customer need 4 What are the unit economics of this business (gross margin, incremental returns)? Do they get better or worse at scale? Where does the money it earns go? — 5/10 Unit economics 5 For it to rise fivefold in ten years, what conditions must all hold at once? Are they realistic? What expectations does today's share price already imply? — 2/10 5x path 2 Why hasn't the market grasped all this yet — does it not understand, not respect it, or not see far enough? What would become the “narrative inflection point”? — 3/10 Blind spot 3
  • How high is its market ceiling — is it growing a slice of an existing pie, or creating an entirely new market?4/10

    Investor is not creating a market; it is a claim on markets other companies create. So the ceiling has to be asked about the pool of assets it can own, and about the size at which its own scale starts to bite.

    The measurable starting point is total adjusted assets of SEK 1,238.0bn at 2026-06-30: SEK 946.2bn listed (76%), SEK 207.9bn Patricia excluding cash (17%) and SEK 88.4bn EQT (7%), giving adjusted NAV of SEK 1,214.7bn after net debt of SEK 23.3bn. Investor's Annual Report 2025 describes the company as the largest on Nasdaq Stockholm by market capitalization among primary-listed companies at 2025 year-end — I verified that line. Being the biggest listed entity in your home market is itself a ceiling signal: the pool of Swedish assets large enough to move a SEK 1.2tn NAV is small and already largely owned, in several cases by Investor.

    The size arithmetic is unforgiving. Doubling NAV means finding another SEK 1,214.7bn of value; a five-fold rise means SEK 6,073bn. The report offers no external estimate of the addressable pool and I did not verify one, so I will not put a number on it — but the portfolio itself shows the direction. The five largest listed holdings are SEK 704.4bn, or 56.9% of adjusted assets (279.0 + 163.8 + 94.0 + 84.7 + 82.9 = 704.4; 704.4 ÷ 1,238.0 = 56.9%). The report's "roughly 58%" comes from summing the rounded individual weights of 23%, 13%, 8%, 7% and 7%. At that concentration, incremental NAV growth is mostly a bet on a handful of very large companies, not on finding new pies.

    Where the pie can genuinely be enlarged is Patricia and EQT. Patricia's 2025 look-through scale was SEK 68.4bn of sales and SEK 17.2bn of EBITDA across wound care, diagnostics, urology, mobility and industrial automation — global end markets in which its companies are mid-sized, so their own ceilings remain far away even if Investor's does not. Investor put SEK 16,148m to work there in 2025. EQT extends the reach into private markets outside Sweden.

    The structural cap the report names correctly is replication rather than addressable market: 76% of adjusted assets can be bought directly, which limits how large a sustained premium the wrapper can carry no matter how big the asset pool becomes. That is a ceiling on valuation, not on size — and at a 1.24% premium on Investor's own market-capitalization basis (SEK 1,229.8bn ÷ SEK 1,214.7bn on 2026-09-10), it is already binding.

    11 сентября 2026 г.
  • Can its revenue at least double over the next five years? Is that growth driven mainly by volume, price, or new businesses?3/10

    "Revenue" is the wrong meter here, and the report says so plainly: Q2 2026 consolidated net sales of SEK 17,904m alongside consolidated profit of SEK 117,290m describe an accounting perimeter, not a business. The sales line is essentially Patricia's consolidated subsidiaries; the profit line is dominated by fair-value movements on listed stakes. I confirmed both figures in Investor's Q2 2026 report, which also gives H1 2026 net sales of SEK 34,034m against SEK 31,770m in H1 2025, up 7.1%.

    Taken literally, doubling that line in five years requires 2^(1/5) − 1 = 14.9% a year. Patricia's organic constant-currency growth was 7% in Q2 2026 and 3% in Q1 2026, so organic volume and price get roughly half the way. The rest would have to come from acquisitions inside Patricia — which is exactly how the line moved in 2025, when Investor deployed SEK 16,148m including Nova Biomedical through Advanced Instruments at USD 2.2bn, against SEK 2,842m in 2024. So a literal doubling is achievable but would be an M&A outcome, not a demand outcome, and it would tell a shareholder almost nothing, because buying revenue with balance-sheet capacity does not by itself raise NAV per share.

    The meaningful translation is adjusted NAV per share, and the arithmetic there is more encouraging. Doubling NAV also needs 14.9% a year. Investor's Q2 2026 report puts five-year annualized adjusted NAV growth with dividend added back at 14.8% to 2026-06-30, and one-year growth at 28.2%; at 14.8%, NAV doubles in 5.0 years. Per-share NAV growth excluding the dividend has been slower: SEK 248 at 2021 year-end to SEK 397 at 2026-06-30 is (397/248)^(1/4.5) − 1 = 11.0% a year, or about 12.4% adding back the SEK 22.40 per share paid out over that window.

    So the defensible answer is that doubling NAV per share within five years sits at the optimistic edge of the record rather than in the base case. The report underwrites high-single-digit NAV growth in its base case and low-single-digit in the conservative one, reaching a SEK 420 base-case value against the SEK 402.75 close of 2026-09-10 — 4.3% above it before the dividend.

    As for the driver mix, the split is unusual: roughly 76% of the outcome is the share-price performance of companies Investor does not operate, 17% is Patricia's blend of organic growth and bolt-ons, and 7% is EQT's cycle. Volume and price in the classic sense apply only to that middle 17%.

    11 сентября 2026 г.
  • Five years out, what takes over as the next growth engine? Does that “second curve” exist today?4/10

    For a holding company the "second curve" question becomes: which bucket takes over as the marginal source of NAV growth? The candidates already exist and are already funded.

    The current engine is unambiguous — Listed Companies, SEK 946.2bn of SEK 1,238.0bn of adjusted assets, which returned 14% in Q2 2026. Within it, ABB did the work: I checked Investor's own tables and ABB's value rose from SEK 182,966m at 2025 year-end to SEK 278,983m at 2026-06-30, up 52.5%, on an unchanged 265,385,142 shares. That is price, not accumulation, and it cannot be the engine for another five years without heroic multiple assumptions.

    The most credible baton is Patricia Industries, and the report identifies why. In Q2 2026 the major subsidiaries grew reported sales 6%, organic constant-currency sales 7%, reported EBITA 13% and adjusted EBITA 16%, while the business area's total return was negative 3% because multiples fell. Value is being created there and not yet recognized. The scale is real — SEK 68.4bn of 2025 look-through sales and SEK 17.2bn of EBITDA, a 25.1% margin — and so is the reinvestment: SEK 16,148m deployed into Patricia in 2025 against SEK 2,842m in 2024, including Nova Biomedical through Advanced Instruments at USD 2.2bn. Nova was already growing organic sales about 10% with roughly 20% earnings growth in Q2 2026. But Patricia has not gained weight: SEK 208,110m at 2025 year-end against SEK 207,905m at 2026-06-30, still 17% of assets. It can only take over if the marks start following the earnings.

    EQT is the smaller, more cyclical candidate at 7% of assets, and Investor is behaving as though it believes in it. The stake went from 177,258,357 EQT AB shares at 2025 year-end to 183,288,016 at 2026-06-30, bought for SEK 1,378m plus SEK 349m at an average of about SEK 286 a share, while the implied mark fell from SEK 368.3 to SEK 274.4. That is counter-cyclical accumulation, but the payoff depends on a fundraising and realization cycle nobody controls, and the business area still declined 2% in Q2.

    The honest limitation: none of these is a second curve in the growth-investing sense. There is no new business line, no new addressable market and no venture option visible in the Q2 2026 disclosure — the same three buckets simply take turns leading. That is consistent with the report underwriting 8–10% annualized NAV-based returns in its base case rather than a re-acceleration, and it is why the growth lens fits this company poorly.

    11 сентября 2026 г.
  • What is its core competitive advantage? Will that moat widen or narrow over the next three to five years?6/10

    Four advantages, of which only three look durable.

    The strongest is cost. Rolling twelve-month management cost was SEK 803m at 2026-06-30 against adjusted NAV of SEK 1,214.7bn — 0.066%, reported as 0.07%; the year-earlier pair was SEK 777m and 0.08%. I verified both in Investor's Q2 2026 report. A seven-basis-point wrapper on SEK 1.2tn is a hurdle almost no pooled active structure can match, and it widens mechanically with scale because the ownership organization is close to fixed.

    Second is governance access that money alone cannot buy. At 2026-06-30 Investor held 39.7% of Saab's votes on 30.2% of its capital, 24.8% of Ericsson's on 9.9%, 33.9% of Husqvarna's on 16.8%, 22.3% of Atlas Copco's on 17.1% and 22.7% of Epiroc's on 17.1%. An index buyer replicates the economics and none of the board seats.

    Third is balance-sheet optionality: net debt of SEK 23.3bn, leverage of 1.9% against a 0–10% policy range, gross cash of SEK 28.8bn and average debt maturity of 8.7 years. That is what lets Investor fund a SEK 1,701m rights issue or add to EQT AB into a 25% price decline instead of selling into weakness.

    Fourth — permanent capital with no redemption or fund clock — is genuine but shared with every family holding company in the report's comparison set, so it differentiates Investor from funds, not from Lundbergföretagen, Sofina or Exor.

    The three-to-five-year direction is mixed, and the report's framing of it is right. Cost and balance-sheet edges should widen. The replication problem should worsen: 76% of adjusted assets are listed and buyable directly, and I verified that concentration is rising without any decision by Investor — ABB's weight went from 16% of adjusted assets at 2025 year-end to 23% at 2026-06-30 on an unchanged 265,385,142 shares, taking ABB plus Atlas Copco from 29% to 36%. The more the NAV is two liquid industrial names, the weaker the case for paying for the wrapper. Patricia at 17% is the part that cannot be replicated, and it is not gaining share: SEK 208,110m at 2025 year-end versus SEK 207,905m at 2026-06-30.

    The governance edge is the one I would call structurally exposed, though I could not verify any live threat to it. It rests on a dual-class regime that gives A shares 87.2% of the votes on 40.6% of the capital. That is a legal privilege rather than an earned one, and its persistence is a policy assumption, not a business fact. On balance: the moat stays strong in absolute terms and narrows in relative terms, because the replicable share of the assets is growing faster than the unreplicable share.

    11 сентября 2026 г.
  • If its core business were disrupted, does it have the DNA to reinvent itself? How does it handle mistakes and bad news?6/10

    Reinvention is the capability this company's record demonstrates most clearly, because it has had to do it repeatedly. The report traces five stages: creation in 1916, when Swedish banking rules forced industrial equities out of Stockholms Enskilda Bank; the 1919 listing; postwar network ownership; a restructuring phase from the 1970s to the mid-1990s out of which EQT emerged; internationalization through AstraZeneca and the Mölnlycke acquisition; and the current three-business-area structure, with estimated market values published for Patricia since 2017. Investor's Annual Report 2025 confirms the 1916 founding and the 1919 listing. Investor's own corporate-history material also confirms the 1924 purchase of Astra for the nominal amount of SEK 1, so that detail stands rather than being company lore.

    The structural point matters more than the anecdotes: Investor's core business is reallocation itself, so "core business disrupted" means something different than for an operating company. The industries underneath can be disrupted while the owner survives, which is exactly what a century of portfolio turnover shows. EQT AB's 2019 IPO is the cleanest example of the reflex — Investor treated the listing as a re-pricing, not an exit, and still held 14.9% of EQT AB's capital and votes at 2026-06-30.

    On bad news, the evidence is stronger than the report draws out, and I checked it in Investor's own Q2 2026 portfolio table. Across H1 2026, while Patricia's major subsidiaries grew organic constant-currency sales 7% and adjusted EBITA 16% in Q2, Investor cut its own estimated values: Permobil from SEK 15,368m to SEK 12,627m, Sarnova from SEK 20,147m to SEK 18,870m, Laborie from SEK 31,820m to SEK 30,265m, Piab from SEK 11,951m to SEK 11,001m, and Atlas Antibodies from SEK 744m to SEK 461m — a 38% mark-down on a company it controls 95.1% of, following a SEK 1.4bn goodwill impairment there at 2025 year-end. The business area printed negative 3% for the quarter on those marks, and negative 9% for full-year 2025. A promoter would have smoothed them; Investor published them alongside the improving operating numbers.

    The counterweight is that Investor sets those marks itself. The methodology is disclosed — median multiples from relevant listed peers, usually enterprise value to LTM operating profit or EBITDA, less net debt and adjusted for ownership, with recently acquired companies held at acquisition value for a period — but the company-specific multiples and private net-debt bridges are not. So the willingness to mark down is demonstrated; the accuracy of the marks cannot be independently verified from public disclosure, and that gap is a permanent feature of owning 17% of the assets this way.

    11 сентября 2026 г.
  • Does management — the founders especially — hold a long-term view with interests deeply tied to the company? Are they willing to sacrifice current profit for the payoff five to ten years out?7/10

    Alignment here runs through a controlling owner rather than a founder. The Knut and Alice Wallenberg Foundation holds 20.07% of the capital and 42.96% of the votes on the report's figures; Investor's Annual Report 2025 states the same position rounded to 20.1% and 43.0%, and lists two further Wallenberg foundations among the ten largest holders (the Marianne & Marcus Wallenberg Foundation at 1.9% of capital and 4.1% of votes). A foundation owner has no fund life, no redemption calendar and no career clock — the structural precondition for a long horizon.

    Personal alignment is smaller but real. The report gives CEO Christian Cederholm 55,200 A and 180,800 B shares, 236,000 in total. I could not verify the A-share figure: Investor's Annual Report 2025 discloses 46,700 A and 180,800 B, 227,500 shares, worth about SEK 91.5m at the 2026-09-10 closes of SEK 399.50 and SEK 402.75 (46,700 × 399.50 + 180,800 × 402.75 = SEK 91.47m). The B count matches exactly, so the report's number is plausibly a later snapshot, but I mark 55,200 as unverified. More telling than any single holding: the Annual Report 2025 states that 100% of Investor employees took part in the 2025 long-term share programme, each investing roughly 10–15% of gross base salary in Investor shares.

    On willingness to trade present profit for value five to ten years out there is behavioural evidence, not just rhetoric. In the Q2 2026 CEO statement Cederholm writes that in ten years the companies' prospects for profitable growth "should look at least as attractive as they do today. If they do not, we have allowed short-term performance at the expense of long-term value creation." The actions match. Investor kept buying EQT AB straight through a de-rating, going from 177,258,357 shares at 2025 year-end to 183,288,016 at 2026-06-30 — SEK 1,378m in Q1 plus SEK 349m in Q2, an average of about SEK 286 a share (1,727 ÷ 6,029,659) — while the implied mark fell from SEK 368.3 to SEK 274.4, down 25.5%. It funded its full SEK 1,701m pro-rata share of Electrolux's rights issue. It let Piab's profitability fall on restructuring and commercial-organization costs rather than defer the work. And it paid a 2025 dividend of SEK 5.60 per share (SEK 4.00 on 2026-05-15, SEK 1.60 due 2026-11-12) at a payout ratio of 112% of accounting earnings, funded by portfolio cash flow rather than earnings optics.

    The limit is governance, not intent: Class B carries 0.1 vote, so an outside shareholder has no mechanism to change course if this discipline ever lapses.

    11 сентября 2026 г.
  • If it disappeared tomorrow, how badly would customers miss it? Is the way it grows sustainable, without relying on harm to society or regulators?4/10

    Investor has no customers in the ordinary sense, so the question resolves into two counterparties: the companies it owns and its own shareholders.

    For the portfolio companies the honest answer is that a few would miss it badly and most would survive. The report's structural point is that 76% of adjusted assets — SEK 946.2bn of SEK 1,238.0bn — are listed companies that already run themselves and would simply wake up with a different share register. What would disappear is a specific governance input: at 2026-06-30 Investor held 39.7% of Saab's votes on 30.2% of capital, 24.8% of Ericsson's on 9.9%, 33.9% of Husqvarna's on 16.8%, 32.3% of Electrolux Professional's on 20.4% and 31.4% of Electrolux's on 18.5%. I checked this table against Investor's own filing; it also discloses the SEB, Sobi, Nasdaq and Wärtsilä voting stakes at 22.1%, 34.4%, 10.3% and 17.7%, which the report leaves as dashes. Removing a stable anchor owner from companies in mid-restructuring is a real loss — Investor put SEK 1,701m into Electrolux's rights issue in Q2 2026, capital a dispersed register supplies far less reliably.

    The businesses that would miss it most are Patricia's: Mölnlycke at 99.8% owned and SEK 75.3bn, Nova Biomedical at 99.2% and SEK 31.4bn, Laborie at 98.5% and SEK 30.3bn. They have no listing, no fund clock and no exit deadline. This is where permanent capital does something an index cannot.

    On whether the growth model is sustainable and free of social or regulatory damage, the mechanism itself is benign: Investor grows by owning assets that grow, not by extracting from customers, and the central cost of 0.07% of NAV means very little of the portfolio's return is consumed by the wrapper. Two qualifications belong here. First, the regulatory dependency is real and historic — the company exists because a 1916 change in Swedish banking rules pushed industrial equities out of Stockholms Enskilda Bank, and its control today rests on a legal dual-class structure in which A shares carry one vote and B shares one-tenth, giving A shares 87.2% of the votes on 40.6% of the capital (Investor Q2 2026). Any Swedish or EU move against dual-class voting would strike at the model. I found no such live proposal in what I checked, so I treat it as an unverified risk rather than a current one. Second, 7% of adjusted assets sit in Saab, whose Q2 wins the CEO listed as A26 submarines for Poland, Gripen jets for Ukraine and GlobalEye selected by Canada and NATO. That is legitimate business many ESG mandates nonetheless exclude, and it is a material part of the recent NAV story.

    11 сентября 2026 г.
  • What are the unit economics of this business (gross margin, incremental returns)? Do they get better or worse at scale? Where does the money it earns go?5/10

    There is no gross margin at the Investor level. The holding-company translation is cost per unit of asset owned, incremental return on capital deployed, and where the cash goes.

    On cost the economics are exceptional and improve with scale. The report cites rolling twelve-month management cost of SEK 803m at 2026-06-30, about 0.07% of adjusted NAV; Investor's Q2 2026 interim report states the same figure and gives the year-earlier pair of SEK 777m and 0.08%. Cost therefore rose 3.3% (803 ÷ 777) while adjusted NAV with dividend added back rose 28.2% over the same twelve months — textbook positive operating leverage. The Annual Report 2025 five-year summary keeps the ratio between 0.07% and 0.09% since 2021. Bigger is better here, because the ownership organization is close to fixed and the asset base is not.

    On incremental returns the honest answer is that they are not directly observable, and the report is right to refuse a consolidated ROIC when SEK 946.2bn of listed stakes are marked while Patricia's SEK 207.9bn is consolidated. The nearest look-through measure it supplies is Patricia's 2025 scale: SEK 68.4bn of sales and SEK 17.2bn of EBITDA, a 25.1% margin (17.2 ÷ 68.4). Dividing the SEK 207.9bn Patricia value by SEK 17.2bn gives 12.1×, but that is an equity-value-to-EBITDA ratio, not EV/EBITDA, because Investor's estimated market values are already net of the subsidiaries' debt; it must not be set against peer EV/EBITDA multiples. The return on the 2025 deployment — SEK 16,148m into Patricia, including Nova Biomedical through Advanced Instruments at USD 2.2bn — cannot be verified yet; the only read so far is Nova's roughly 10% organic sales growth and about 20% earnings growth in Q2 2026.

    Where the money goes is fully traceable and it reconciles. From Investor's 2025 five-year summary: in came dividends of SEK 16,185m (SEK 15,410m from Listed Companies), Patricia distributions of SEK 9,192m, EQT proceeds of SEK 6,976m and divestments of SEK 1,772m — SEK 34,125m. Out went the shareholder dividend of SEK 15,929m, Patricia investments of SEK 16,148m, EQT draw-downs of SEK 10,089m, listed purchases of SEK 2,428m and management cost of SEK 795m — SEK 45,389m. The SEK 11,264m gap matches the rise in net debt from SEK 12,194m to SEK 23,387m almost exactly. One caveat on the leverage row: the report reproduces Investor's own five-year summary, which shows a flat "2%" for every year 2021–2025, but that summary's 2024 column does not reconcile with itself — total assets of SEK 981,951m less adjusted NAV of SEK 969,756m implies net debt of SEK 12,195m and leverage of 1.3%, not the SEK 21,194m and 2% printed. Investor's Q4 2025 report gives 1.2% for 2024. The flat row therefore rounds away a real increase used to fund Patricia.

    11 сентября 2026 г.
  • For it to rise fivefold in ten years, what conditions must all hold at once? Are they realistic? What expectations does today's share price already imply?2/10

    Five times in ten years from SEK 402.75 means SEK 2,013.75, a price CAGR of 5^(1/10) − 1 = 17.46%. Three conditions would have to hold together.

    First, NAV per share has to do almost all the work. At an unchanged price/NAV of about 1.0×, NAV per share must go from SEK 397 to SEK 2,013.75, which is 5.07× or 17.6% a year (2,013.75 ÷ 397 = 5.072; 5.072^0.1 = 1.176). Allow the shares to end on a 10% premium instead and the required NAV is SEK 1,830.68 (2,013.75 ÷ 1.10), still 16.5% a year. The realized comparison: adjusted NAV per share went from SEK 248 at 2021 year-end to SEK 397 at 2026-06-30, so (397/248)^(1/4.5) − 1 = 11.0% a year before dividends, or about 12.4% adding back the SEK 22.40 per share paid out over that window. Investor's own Q2 2026 report gives five-year annualized adjusted NAV growth with dividend added back of 14.8% — I checked this in the interim report, and 14.8% doubles NAV in 5.0 years; it does not quintuple it in ten.

    Second, no help from the wrapper. The report shows discount compression was historically the second engine — 13% at the 2022 and 2023 year ends, 7% in 2025, a small premium now. From roughly 1.0×, that term can realistically only subtract.

    Third, all three buckets must perform for a decade: ABB and Atlas Copco, 36% of the SEK 1,238.0bn of adjusted assets, compounding without multiple compression; Patricia, 17%, converting its 7% organic and 16% adjusted EBITA growth into marks; and EQT, 7%, getting a private-markets cycle. The report's own 3–5 year underwriting is 8–10% annualized in the base case and 12–14% in the optimistic case. Neither reaches 17.5%.

    So the honest verdict is that a five-fold decade is not realistic on the report's own numbers; it would require roughly 60% more annual NAV compounding than the last four and a half years delivered, on a far larger base.

    What the price implies today: at SEK 402.75 against unrounded NAV per share of SEK 396.51 (SEK 1,214,733m ÷ 3,063,530,101 shares), the market pays 1.6% above stated asset value, or 1.24% measured the way Investor measures it, on market capitalization. That embeds almost nothing beyond the assets: future ownership value-add roughly offsets the SEK 803m of annual central cost and the private-mark uncertainty, no more. Expected return therefore collapses to expected NAV return — the report's base case is +5.7% over twelve months including a SEK 5.60 dividend proxy.

    11 сентября 2026 г.
  • Why hasn't the market grasped all this yet — does it not understand, not respect it, or not see far enough? What would become the “narrative inflection point”?3/10

    The question assumes an unrecognized story, and for this company that assumption has to be inverted. The report's central finding is that the market has already re-rated Investor: the five-year summary it reproduces shows year-end discounts to adjusted NAV of 7%, 13%, 13%, 8% and 7% across 2021–2025, and at SEK 402.75 on 2026-09-10 the shares trade above the last reported NAV of SEK 1,214.7bn. I checked Investor's Annual Report 2025 directly, and that discount row is computed from the total market capitalization of both share classes against adjusted NAV — 2025: SEK 1,009,998m ÷ SEK 1,087,082m = a 7.1% discount — not from the B price alone. Put 2026-09-10 on the same basis and the premium is SEK 1,229.8bn ÷ SEK 1,214.7bn = 1.24%; on the report's class-B-versus-SEK 397 basis it is 1.45%. Either way, "the market looks down on it" has stopped being true.

    What is plausibly still under-appreciated is narrower: Patricia Industries. The Q2 2026 disclosure shows the major subsidiaries growing organic constant-currency sales 7% and adjusted EBITA 16% while the business area's total return was negative 3%, purely because valuation multiples fell. Q1 2026 was the mirror image — a positive 4% estimated return against reported sales down 7%, organic growth of 3% and adjusted EBITA down 4%. This is not the market misreading operations; it is a mark-to-model asset whose peer multiples move faster than its earnings. Checking Investor's Q2 portfolio table myself, several Patricia marks were cut during H1 2026 even as the businesses grew: Permobil SEK 15,368m to SEK 12,627m, Sarnova SEK 20,147m to SEK 18,870m, Piab SEK 11,951m to SEK 11,001m, Atlas Antibodies SEK 744m to SEK 461m. Earnings compounding underneath falling multiples is genuinely hard to see.

    Three narrative inflection points are observable rather than speculative. First, Patricia's marks catching up: two or three more quarters of mid-to-high-single-digit organic growth with stable multiples would let value follow earnings, which the report calls the cleanest upside that does not require public multiple expansion. Second, concentration. I verified that ABB's weight moved from 16% of adjusted assets at 2025 year-end to 23% at 2026-06-30 on an unchanged 265,385,142 shares — pure price — taking ABB plus Atlas Copco from 29% to 36%. A de-rating there rewrites the story quickly. Third, the discount reopening, which the report treats as paradoxically good for a new buyer. The exact date of the Q3 2026 report is flagged as unverified in the report, and I did not verify it either.

    11 сентября 2026 г.
Задать вопрос по этому отчёту

Подписчики могут задать вопрос по этому отчёту; после ответа он появится в разделе «Вопросы читателей» на этой странице. Также можно выделить фрагмент текста и спросить о нём напрямую.